Scroll To Top
Search by Speciality

International Academy of Cardiology, Annual Scientific Sessions 2014, 19th World Congress on Heart Disease

Hyatt Regency Hotel Boston * | Boston, USA
From 160 to 740 USD
Event Preview
This event
is Finished
Title: International Academy of Cardiology, Annual Scientific Sessions 2014, 19th World Congress on Heart Disease
Specialty: , Cardiology
Dates: From Jul, 25, 2014 to Jul, 28, 2014
Location: Boston, USA
Type: Congress
Registration Cost: From 160 to 740 USD
Event Tools
  • Add to Favorites
  • Claim this event
Add to my Calendar
  • Scientific Programm
  • Online registration
  • Exhibition floorplans
  • Sponsorship &
    Exhibition consensus
  • Virtual Booths
Weather Info (monthly averages) Max Temperature: C / F Min Temperature: C / F The above data in our Weather Info table are temperature predictions for the date of the medical event for BOSTON, Usa.
General Info
Event Venue:

Hyatt Regency Hotel Boston *

BOSTON, USA Visit the Venue to read more
Event Overview
Welcome message:

Dear Friend and Colleague,

On behalf of the Organizing Committee, it is my great pleasure to invite you to participate in the International Academy of Cardiology, Annual Scientific Sessions 2014, 19th WORLD CONGRESS ON HEART DISEASE, Boston, MA, USA, July 25-28, 2014.

The Congress will provide the opportunity for a comprehensive overview of the latest research developments in cardiovascular medicine, primarily in the areas of molecular biology, coronary artery disease, heart failure, cardiac arrhythmias and cardiac surgery.

Plans for this CME meeting are progressing extremely well. Many distinguished cardiologists and scientists have agreed to join the faculty participating in this Congress. Papers will be presented in the form of plenary sessions, symposia and posters, and will include superb scientific material originating from numerous laboratories around the globe, assuring that the meeting will be a major scientific event.

Program areas will range from clinical pathophysiology to evaluation and stratification techniques and molecular and cellular biology, including neurohumoral, immunological and genetic studies. We will discuss new and innovative diagnostic methods, prevention and treatment of heart disease, and prognostic algorithms. Integrated into the program will be an update on the latest major clinical trials.

We hope that you will participate in this Congress and submit for presentation your most recent scientific work in the rapidly evolving field of cardiovascular disease.

Your interaction with your colleagues from many different countries will stimulate a creative exchange of ideas and will be personally rewarding. We look forward to your active participation in the 19th WORLD CONGRESS ON HEART DISEASE and to welcoming you to the beautiful city of Boston in July.

Yours sincerely,

Asher Kimchi, MD

Registration Not yet available Register Now

The Hyatt Regency Boston
The Hyatt Regency Boston
One Avenue de Lafayette 
Boston, Massachusetts 

Tel: +1 617 912 1234 
Fax: +1 617 451 2198


The Hyatt Regency Boston in Boston, MA, USA is the venue and headquarters hotel of the International Academy of Cardiology, Annual Scientific Sessions 2014, 19th WORLD CONGRESS ON HEART DISEASE and will be offering specially reduced rates for Congress participants as listed below:

Single Double Triple Quad
$235 $235 $260 $285


Rates are quoted in American Dollars and are per room, per night, on room only basis.

These rates are only available until July 4, 2014 or until all blocked rooms have been reserved. Rates are per night and are excluding tax.

Reservations received after this date will be booked on a "space available basis", and if group rates will not be available, the prevailing room rates will apply for any reservation confirmed.

The Hyatt Regency Boston’s room rates are subject to the following state and local taxes, which are currently 14.45%.

Scientific Content Up to Date
Submission Info
Select one category, under which your abstract will be reviewed:

1. Molecular cardiology, Basic research 
2. Vascular biology, Basic research 
3. Pharmacologic modulation of vascular-endothelial function 
4. Genetic determinants of coronary heart disease/cardiomyopathies 
5. Gene transfer and therapy 
6. Biochemical markers of acute ischemia 
7. Contrast echocardiography 
8. Pharmacologic stress testing - Echocardiography 
9. Echocardiography: TEE and 3-D 
10. Nuclear Cardiology 
12. Other diagnostic methods: Percutaneous coronary angioscopy / intravascular ultrasound imaging /intracoronary flow, doppler measurements 
13. The plaque and acute coronary syndromes 
14. Myocardial stunning, Hibernation and preconditioning 
15. Acute myocardial infarction: thrombolysis and reperfusion 
16. Angioplasty therapy for acute MI 
17. Stents: new devices/optimal application/multiple stents 
18. Antithrombotic and antiplatelet adjunctive therapy for PTCA 
19. Blockade of tissue proliferation after coronary interventions 
20. Restenosis - use of ionizing radiation 
21. Nitrates, beta blockers, calcium entry blockers and ACE inhibition drugs for ischemic heart disease 
22. Left ventricular remodeling after MI 
23. Secondary prevention, prognosis, risk stratification, cardiac rehab 
24. Modification of lipoproteins and coronary disease 
25. Hypertension, basic and clinical 
26. Diabetes mellitus, obesity, insulin and atherosclerosis 
27. Primary prevention of coronary artery disease in the healthy adult and children 
28. Hormone therapy in postmenopausal women 
29. Natriuretic peptides, endothelin: role in heart failure 
30. Neurohumoral, immunologic and cytokine aspects of heart failure 
31. Nitric oxide and nitric oxide synthase in heart failure 
32. Myocyte and receptor abnormalities in heart failure 
33. Dilated cardiomyopathy: various etiologies 
34. Left ventricular hypertrophy and hypertrophic cardiomyopathy 
35. Role of the pericardium - basic and clinical 
36. Pulmonary circulation aspects, pulmonary hypertension 
37. Predictors and markers of heart failure outcome 
38. Exercise physiology in heart failure 
39. Renal aspects - diuretics 
40. Digoxin and other new inotropic agents in heart failure 
41. ACE inhibitors and Angiotensin-ll receptor blockers 
42. Organic nitrates-their role in heart failure management 
43. Beta-blockers and beta-adrenergic receptors in heart failure 
44. Calcium channel blockers and promoters in heart failure 
45. Arrhythmias and antiarrhythmic drug therapy - basic and clinical 
46. Sudden death 
47. Electrophysiologic techniques of mapping and radiofrequency ablation 
48. Internal defibrillation/implantable antiarrhythmic devices/pacing 
49. Pediatric cardiology and cardiac surgery/congenital heart disease 
50. Angioplasty or surgery for multivessel coronary artery disease 
51. New approaches to surgical revascularization: minimally invasive surgery, TMLR 
52. Valvular heart disease/Heart valve surgery-adult 
53. Mechanical support left ventricular assist devices 
54. Surgery for LV dysfunction 
55. Cardiac transplantation 
56. Practice guidelines, cost containment 
57. Computers in cardiology 
58. Miscellaneous

Sponsors Exhibitors
Organising Agency

18th World Congress on Heart Disease
PO Box 17659, Beverly Hills, CA 90209, USA

Tel: +1 310 657 8777
Fax: +1 310 659 4781

Event map
Revelant Events